Genelux Corporation

This study is testing a new two-step treatment for advanced non-small cell lung cancer that has started to grow again after initial therapy. One group receives an intravenous modified virus designed to attack cancer cells, followed by standard chemotherapy and immunotherapy. The …

This study is testing if a modified virus called Olvi-Vec, given directly into the abdomen, can help chemotherapy work better for women with ovarian cancer that has stopped responding to standard platinum drugs. Participants will be randomly assigned to receive either the virus f…